GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
68 hedge funds and large institutions have $91.2M invested in Aevi Genomic Medicine Inc in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
68
Holding in Top 10
1
Calls
$379K
Puts
–
Top Buyers
| 1 | +$1.62M | |
| 2 | +$634K | |
| 3 | +$624K | |
| 4 |
NCMW
Northern Capital Management (Wisconsin)
Madison,
Wisconsin
|
+$200K |
| 5 |
BC
Birchview Capital
Burlington,
Vermont
|
+$189K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$836K | |
| 3 | -$555K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$444K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$278K |